$ANDS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANADYS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANADYS PHARMACEUTICALS INC. Get notifications about new insider transactions in ANADYS PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.13 | 200 | 2,026 | 1,326 | 1.5 K to 1.3 K (-13.11 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.16 | 200 | 2,032 | 1,526 | 1.7 K to 1.5 K (-11.59 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.21 | 200 | 2,042 | 1,726 | 1.9 K to 1.7 K (-10.38 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.15 | 400 | 4,060 | 1,926 | 2.3 K to 1.9 K (-17.20 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.14 | 570 | 5,780 | 2,326 | 2.9 K to 2.3 K (-19.68 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.22 | 600 | 6,132 | 2,896 | 3.5 K to 2.9 K (-17.16 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.15 | 100 | 1,015 | 0 | 100 to 0 (-100.00 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.11 | 300 | 3,033 | 100 | 400 to 100 (-75.00 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.13 | 500 | 5,065 | 400 | 900 to 400 (-55.56 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.10 | 600 | 6,060 | 900 | 1.5 K to 900 (-40.00 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Buy | M | 2.95 | 1,500 | 4,425 | 1,500 | 0 to 1.5 K |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.14 | 38 | 423 | 198,744 | 198.8 K to 198.7 K (-0.02 %) |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.04 | 100 | 1,104 | 198,782 | 198.9 K to 198.8 K (-0.05 %) |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.15 | 100 | 1,115 | 198,882 | 199 K to 198.9 K (-0.05 %) |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.97 | 400 | 4,388 | 198,982 | 199.4 K to 199 K (-0.20 %) |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.00 | 400 | 4,400 | 199,382 | 199.8 K to 199.4 K (-0.20 %) |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.01 | 462 | 5,087 | 199,782 | 200.2 K to 199.8 K (-0.23 %) |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.96 | 700 | 7,672 | 200,244 | 200.9 K to 200.2 K (-0.35 %) |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.98 | 800 | 8,784 | 200,944 | 201.7 K to 200.9 K (-0.40 %) |
Jan 18 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.99 | 2,000 | 21,980 | 201,744 | 203.7 K to 201.7 K (-0.98 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Option Exercise | M | 2.95 | 1,500 | 4,425 | 10,265 | |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 10.02 | 100 | 1,002 | 0 | 100 to 0 (-100.00 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 10.01 | 200 | 2,002 | 200 | 400 to 200 (-50.00 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 10.00 | 1,200 | 12,000 | 300 | 1.5 K to 300 (-80.00 %) |
Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Buy | M | 2.95 | 1,500 | 4,425 | 1,500 | 0 to 1.5 K |
Dec 16 2005 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Option Exercise | A | 8.16 | 35,000 | 285,600 | 35,000 | |
Dec 16 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | A | 8.16 | 85,000 | 693,600 | 85,000 | |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.25 | 63 | 520 | 203,744 | 203.8 K to 203.7 K (-0.03 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.35 | 100 | 835 | 203,807 | 203.9 K to 203.8 K (-0.05 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.11 | 100 | 811 | 203,907 | 204 K to 203.9 K (-0.05 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.15 | 200 | 1,630 | 204,077 | 204.3 K to 204.1 K (-0.10 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.09 | 200 | 1,618 | 204,207 | 204.4 K to 204.2 K (-0.10 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.13 | 393 | 3,195 | 204,407 | 204.8 K to 204.4 K (-0.19 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.23 | 400 | 3,292 | 204,800 | 205.2 K to 204.8 K (-0.19 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.03 | 400 | 3,212 | 205,200 | 205.6 K to 205.2 K (-0.19 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.24 | 437 | 3,601 | 205,600 | 206 K to 205.6 K (-0.21 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.02 | 650 | 5,213 | 206,037 | 206.7 K to 206 K (-0.31 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.12 | 1,000 | 8,120 | 206,687 | 207.7 K to 206.7 K (-0.48 %) |
Dec 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.05 | 1,057 | 8,509 | 207,687 | 208.7 K to 207.7 K (-0.51 %) |
Dec 16 2005 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Option Exercise | A | 8.16 | 110,000 | 897,600 | 110,000 | |
Dec 16 2005 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Option Exercise | A | 8.16 | 30,000 | 244,800 | 30,000 | |
Dec 16 2005 | ANDS | ANADYS PHARMACEUTI ... | Crittenden Jennifer K | Vice President, Fin ... | Option Exercise | A | 8.16 | 35,000 | 285,600 | 35,000 | |
Dec 16 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Option Exercise | A | 8.16 | 200,000 | 1,632,000 | 200,000 | |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.58 | 50 | 529 | 208,744 | 208.8 K to 208.7 K (-0.02 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.56 | 50 | 528 | 208,794 | 208.8 K to 208.8 K (-0.02 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.61 | 50 | 531 | 208,844 | 208.9 K to 208.8 K (-0.02 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.67 | 50 | 534 | 208,894 | 208.9 K to 208.9 K (-0.02 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.51 | 100 | 1,051 | 208,944 | 209 K to 208.9 K (-0.05 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.49 | 100 | 1,049 | 209,044 | 209.1 K to 209 K (-0.05 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.47 | 150 | 1,571 | 209,144 | 209.3 K to 209.1 K (-0.07 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.73 | 200 | 2,146 | 209,294 | 209.5 K to 209.3 K (-0.10 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.69 | 200 | 2,138 | 209,494 | 209.7 K to 209.5 K (-0.10 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.41 | 250 | 2,603 | 209,694 | 209.9 K to 209.7 K (-0.12 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.55 | 250 | 2,638 | 209,944 | 210.2 K to 209.9 K (-0.12 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.66 | 350 | 3,731 | 210,194 | 210.5 K to 210.2 K (-0.17 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.48 | 350 | 3,668 | 210,544 | 210.9 K to 210.5 K (-0.17 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.62 | 350 | 3,717 | 210,894 | 211.2 K to 210.9 K (-0.17 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.64 | 493 | 5,246 | 211,244 | 211.7 K to 211.2 K (-0.23 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.57 | 550 | 5,814 | 211,737 | 212.3 K to 211.7 K (-0.26 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.65 | 557 | 5,932 | 212,287 | 212.8 K to 212.3 K (-0.26 %) |
Nov 22 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.63 | 900 | 9,567 | 212,844 | 213.7 K to 212.8 K (-0.42 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.12 | 100 | 1,112 | 213,744 | 213.8 K to 213.7 K (-0.05 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.92 | 100 | 1,092 | 213,844 | 213.9 K to 213.8 K (-0.05 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.88 | 100 | 1,088 | 213,944 | 214 K to 213.9 K (-0.05 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.83 | 100 | 1,083 | 214,044 | 214.1 K to 214 K (-0.05 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.73 | 100 | 1,073 | 214,144 | 214.2 K to 214.1 K (-0.05 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.91 | 300 | 3,273 | 214,244 | 214.5 K to 214.2 K (-0.14 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.78 | 400 | 4,312 | 214,544 | 214.9 K to 214.5 K (-0.19 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.89 | 400 | 4,356 | 214,944 | 215.3 K to 214.9 K (-0.19 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.74 | 500 | 5,370 | 215,344 | 215.8 K to 215.3 K (-0.23 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.90 | 900 | 9,810 | 215,844 | 216.7 K to 215.8 K (-0.42 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.93 | 900 | 9,837 | 216,744 | 217.6 K to 216.7 K (-0.41 %) |
Oct 18 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.14 | 1,100 | 12,254 | 217,644 | 218.7 K to 217.6 K (-0.50 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.37 | 75 | 1,003 | 218,744 | 218.8 K to 218.7 K (-0.03 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.19 | 100 | 1,319 | 218,819 | 218.9 K to 218.8 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.30 | 100 | 1,330 | 218,919 | 219 K to 218.9 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.46 | 100 | 1,346 | 219,019 | 219.1 K to 219 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.48 | 100 | 1,348 | 219,119 | 219.2 K to 219.1 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.49 | 100 | 1,349 | 219,219 | 219.3 K to 219.2 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.52 | 100 | 1,352 | 219,319 | 219.4 K to 219.3 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.53 | 100 | 1,353 | 219,419 | 219.5 K to 219.4 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.54 | 100 | 1,354 | 219,519 | 219.6 K to 219.5 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.57 | 100 | 1,357 | 219,619 | 219.7 K to 219.6 K (-0.05 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.51 | 200 | 2,702 | 219,719 | 219.9 K to 219.7 K (-0.09 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.17 | 200 | 2,634 | 219,919 | 220.1 K to 219.9 K (-0.09 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.39 | 225 | 3,013 | 220,119 | 220.3 K to 220.1 K (-0.10 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.28 | 300 | 3,984 | 220,344 | 220.6 K to 220.3 K (-0.14 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.33 | 300 | 3,999 | 220,644 | 220.9 K to 220.6 K (-0.14 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.20 | 800 | 10,560 | 220,944 | 221.7 K to 220.9 K (-0.36 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.18 | 900 | 11,862 | 221,744 | 222.6 K to 221.7 K (-0.40 %) |
Sep 21 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 13.31 | 1,100 | 14,641 | 222,644 | 223.7 K to 222.6 K (-0.49 %) |
Sep 06 2005 | ANDS | ANADYS PHARMACEUTI ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 5,000 | |
Sep 06 2005 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 5,000 | |
Sep 06 2005 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 5,000 | |
Sep 06 2005 | ANDS | ANADYS PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 5,000 | |
Sep 06 2005 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 5,000 | |
Sep 06 2005 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 5,000 | |
Sep 06 2005 | ANDS | ANADYS PHARMACEUTI ... | FISHERMAN JASON S | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 5,000 | |
Aug 17 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.86 | 100 | 1,286 | 223,744 | 223.8 K to 223.7 K (-0.04 %) |
Aug 17 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.91 | 100 | 1,291 | 223,844 | 223.9 K to 223.8 K (-0.04 %) |
Aug 17 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.67 | 400 | 5,068 | 223,944 | 224.3 K to 223.9 K (-0.18 %) |
Aug 17 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.80 | 500 | 6,400 | 224,344 | 224.8 K to 224.3 K (-0.22 %) |
Aug 17 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.90 | 600 | 7,740 | 224,844 | 225.4 K to 224.8 K (-0.27 %) |
Aug 17 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.83 | 800 | 10,264 | 225,444 | 226.2 K to 225.4 K (-0.35 %) |
Aug 17 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.89 | 2,500 | 32,225 | 226,244 | 228.7 K to 226.2 K (-1.09 %) |
Jul 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.18 | 100 | 1,118 | 228,744 | 228.8 K to 228.7 K (-0.04 %) |
Jul 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.24 | 100 | 1,124 | 228,844 | 228.9 K to 228.8 K (-0.04 %) |
Jul 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.23 | 500 | 5,615 | 228,944 | 229.4 K to 228.9 K (-0.22 %) |
Jul 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.33 | 500 | 5,665 | 229,444 | 229.9 K to 229.4 K (-0.22 %) |
Jul 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.26 | 1,000 | 11,260 | 229,944 | 230.9 K to 229.9 K (-0.43 %) |
Jul 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.22 | 1,300 | 14,586 | 230,944 | 232.2 K to 230.9 K (-0.56 %) |
Jul 19 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.25 | 1,500 | 16,875 | 232,244 | 233.7 K to 232.2 K (-0.64 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.22 | 100 | 822 | 233,744 | 233.8 K to 233.7 K (-0.04 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.40 | 100 | 840 | 233,844 | 233.9 K to 233.8 K (-0.04 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.46 | 100 | 846 | 233,944 | 234 K to 233.9 K (-0.04 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.51 | 100 | 851 | 234,044 | 234.1 K to 234 K (-0.04 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.71 | 100 | 871 | 234,144 | 234.2 K to 234.1 K (-0.04 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.76 | 100 | 876 | 234,244 | 234.3 K to 234.2 K (-0.04 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.69 | 100 | 869 | 234,344 | 234.4 K to 234.3 K (-0.04 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.38 | 200 | 1,676 | 234,444 | 234.6 K to 234.4 K (-0.09 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.67 | 200 | 1,734 | 234,644 | 234.8 K to 234.6 K (-0.09 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.78 | 200 | 1,756 | 234,844 | 235 K to 234.8 K (-0.09 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.77 | 500 | 4,385 | 235,044 | 235.5 K to 235 K (-0.21 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.80 | 800 | 7,040 | 235,544 | 236.3 K to 235.5 K (-0.34 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.79 | 1,000 | 8,790 | 236,344 | 237.3 K to 236.3 K (-0.42 %) |
Jun 23 2005 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 8.75 | 1,400 | 12,250 | 237,344 | 238.7 K to 237.3 K (-0.59 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 8.37 | 3,750 | 31,388 | 3,750 | |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 8.37 | 5,000 | 41,850 | 5,000 | |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 8.37 | 5,000 | 41,850 | 5,000 | |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 8.37 | 3,750 | 31,388 | 3,750 | |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Option Exercise | A | 8.37 | 5,000 | 41,850 | 5,000 | |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 8.37 | 5,000 | 41,850 | 5,000 | |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | FISHERMAN JASON S | Director | Option Exercise | A | 8.37 | 5,000 | 41,850 | 5,000 | |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.90 | 5,700 | 45,052 | 2,208,023 | 2.2 M to 2.2 M (-0.26 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.81 | 8,700 | 67,977 | 2,213,723 | 2.2 M to 2.2 M (-0.39 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.80 | 3,100 | 24,180 | 2,222,423 | 2.2 M to 2.2 M (-0.14 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.80 | 11,100 | 86,557 | 2,225,523 | 2.2 M to 2.2 M (-0.50 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.73 | 18,082 | 139,835 | 2,236,623 | 2.3 M to 2.2 M (-0.80 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.70 | 10,680 | 82,249 | 2,254,705 | 2.3 M to 2.3 M (-0.47 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.70 | 44,538 | 342,943 | 2,265,385 | 2.3 M to 2.3 M (-1.93 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.63 | 10,070 | 76,795 | 2,309,923 | 2.3 M to 2.3 M (-0.43 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.60 | 9,909 | 75,308 | 2,319,993 | 2.3 M to 2.3 M (-0.43 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.52 | 15,065 | 113,248 | 2,329,902 | 2.3 M to 2.3 M (-0.64 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.51 | 11,093 | 83,336 | 2,344,967 | 2.4 M to 2.3 M (-0.47 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.50 | 14,550 | 109,176 | 2,356,060 | 2.4 M to 2.4 M (-0.61 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.50 | 36,991 | 277,433 | 2,370,610 | 2.4 M to 2.4 M (-1.54 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.43 | 21,223 | 157,649 | 2,407,601 | 2.4 M to 2.4 M (-0.87 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.41 | 8,500 | 62,974 | 2,428,824 | 2.4 M to 2.4 M (-0.35 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.40 | 59,303 | 438,842 | 2,437,324 | 2.5 M to 2.4 M (-2.38 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.32 | 48 | 399 | 2,496,627 | 2.5 M to 2.5 M (0.00 %) |